Small intestine cancer diagnostic study of choice
Small intestine cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Small intestine cancer diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Small intestine cancer diagnostic study of choice |
Small intestine cancer diagnostic study of choice in the news |
Risk calculators and risk factors for Small intestine cancer diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Diagnostic Study of Choice
Study of choice
- Biopsy is the gold standard test for the diagnosis of small intestine cancer.
- Endoscopy and imaging tests can locate areas that have cancer, but the only way to confirm the diagnosis is to do a biopsy and histopathological analysis.
- There are different ways to take biopsy samples of suspicious lesion.
- There are numerous ways to take biopsy of small intestine:
- Endoscopy: Endoscopy can be used to biopsy the lesions of proximal duodenum to the ligament of Treitz or in the terminal ileum. Push enteroscopes can reach the proximal jejunum, but not distal jejunum and ileum.
- Laprotomy: is needed to biopsy a tumor in the intestines. This may be done if the tumor cannot be reached with an endoscope.
Diagnostic results
The following finding(s) on performing [investigation name] is(are) confirmatory for [disease name]:
- [Finding 1]
- [Finding 2]
Sequence of Diagnostic Studies
The [name of investigation] must be performed when:
- The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
- A positive [test] is detected in the patient, to confirm the diagnosis.
OR
The various investigations must be performed in the following order:
- [Initial investigation]
- [2nd investigation]
Name of Diagnostic Criteria
The American Joint Committee on Cancer (AJCC) has designated staging by TNM classification to define small intestine cancer[1]:
Primary Tumor (T):
TX | Primary tumor cannot be assessed |
T0 | No evidence of primary tumor |
Tis | Carcinoma in situ |
T1a | Tumor invades lamina propria |
T1b | Tumor invades submucosa |
T2 | Tumor invades muscularis propria |
T3 | Tumor invades through the muscularis propria into the subserosa or into the non-peritonealized perimuscular tissue (mesentery or retroperitoneum) with extension ≤2 cm |
T4 | Tumor perforates the visceral peritoneum or directly invades other organs or structures (includes other loops of small intestine, mesentery, or retroperitoneum >2 cm, and abdominal wall by way of serosa; for duodenum only, invasion of pancreas or bile duct) |
Regional Lymph Nodes (N)
- NX- Regional lymph nodes cannot be assessed
- N0- No regional lymph node metastasis
- N1- Metastasis in 1–3 regional lymph nodes
- N2- Metastases in ≥4 regional lymph nodes
Distant Metastasis (M)
- M0- No distant metastasis
- M1- Distant metastasis
AJCC Stage Groupings
Stage | T | N | M |
0 | Tis | N0 | M0 |
I | T1 | N0 | M0 |
II | T2 | N0 | M0 |
IIA | T3 | N0 | M0 |
IIB | T4 | N0 | M0 |
IIIA | Any T | N1 | M0 |
IIIB | Any T | N2 | M0 |
IV | Any T | Any N | M1 |